Korean Market
EXCH
Eone Diagnomics Genome Center
★★★

Change of Largest Shareholder Due to Rehabilitation Plan Causes Massive Dilution - Concerns of Plummeting Value for Existing Shareholders

 
MATR
Eone Diagnomics Genome Center
★★★

EDGC Decides on Third-Party Allotment of 165 Billion Won Under Rehabilitation Plan... Massive Dilution at 100 Won Per Share, New Shares Listed on June 12

 
MATR
Eone Diagnomics Genome Center
★★★★

EDGC Announces 83.33% Massive Capital Reduction Following Court-Approved Rehabilitation Plan... Severe Shareholder Dilution Risk and Listing Delay

 
MATR
Eone Diagnomics Genome Center
★★★

EDGC Issues 224.8M Shares via Debt-to-Equity at 76% Discount, Diluting Existing Shareholders by 62%

 
MATR
Eone Diagnomics Genome Center
★★★

EDGC Decides 83.33% Reverse Stock Split Under Rehabilitation Plan... Existing Shareholders Face Massive Dilution and Value Loss

 
MATR
Eone Diagnomics Genome Center
★★★★

Third-Party Allotment under Rehabilitation Plan... Existing Shareholders Diluted by 73%... Change of Control and Fundraising

 
MATR
Eone Diagnomics Genome Center
★★★★

EDGC Issues 224.8 Million New Shares in Debt-to-Equity Swap under Rehabilitation Plan… Massive Dilution Poses Severe Risk to Existing Shareholders

 
OWNR
Eone Diagnomics Genome Center
★

Largest Shareholder Im Gyeong-suk Files Large Shareholding Report with 36.60% Stake

 
OWNR
Eone Diagnomics Genome Center
★

Insider Ownership Report Filed with No Changes

 
OWNR
Eone Diagnomics Genome Center
★

Executive/Major Shareholder Securities Ownership Report Filed (No Changes)

 
OWNR
Eone Diagnomics Genome Center
★

Blank Large Shareholding Report

 
PERI
Eone Diagnomics Genome Center
★★

Rehabilitation Plan Approval Improves Financial Structure, Uncertainty Remains

 
EXCH
Eone Diagnomics Genome Center
★

Record Date Set for Extraordinary General Meeting

 
EXCH
Eone Diagnomics Genome Center
★

Extraordinary General Meeting Convened for Rehabilitation Plan – Appointment and Removal of Directors and Auditor

 
EXCH
Eone Diagnomics Genome Center
★★★

Completion of Capital Reduction in Receivership, Correction of Fractional Share Cancellation, and Reflecting Capital Increase